s-2678 has been researched along with Ewing Sarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adwal, A; Callen, DF; Clayer, MT; Farshid, G; Neuhaus, SJ; Pishas, KI; Staudacher, AH | 1 |
1 other study(ies) available for s-2678 and Ewing Sarcoma
Article | Year |
---|---|
XI-006 induces potent p53-independent apoptosis in Ewing sarcoma.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Calcium-Binding Proteins; Carrier Proteins; Cell Adhesion Molecules; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Cyclic N-Oxides; DNA Damage; DNA-Binding Proteins; Histones; Humans; Intracellular Signaling Peptides and Proteins; Kinesins; Membrane Proteins; MRE11 Homologue Protein; Nuclear Proteins; Oxadiazoles; Phthalazines; Piperazines; Promoter Regions, Genetic; Proto-Oncogene Proteins; Sarcoma, Ewing; Tumor Suppressor Protein p53; Utrophin | 2015 |